BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28534344)

  • 1. Orbital Lymphangioma: Characteristics and Treatment Outcomes of 12 Cases.
    Woo YJ; Kim CY; Sgrignoli B; Yoon JS
    Korean J Ophthalmol; 2017 Jun; 31(3):194-201. PubMed ID: 28534344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of surgical outcome with neuroimaging findings in periocular lymphangiomas.
    Gündüz K; Demirel S; Yagmurlu B; Erden E
    Ophthalmology; 2006 Jul; 113(7):1231.e1-8. PubMed ID: 16730067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital decompression for gross proptosis associated with orbital lymphangioma.
    Hsuan J; Malhotra R; Davis G; Selva D
    Ophthalmic Plast Reconstr Surg; 2004 Nov; 20(6):463-5. PubMed ID: 15599249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit.
    Schwarcz RM; Ben Simon GJ; Cook T; Goldberg RA
    Am J Ophthalmol; 2006 Feb; 141(2):333-9. PubMed ID: 16458690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of orbital lymphangioma with persistent fetal vasculature and extraorbital vascular malformations treated with intralesional bleomycin.
    Hada M; Upadhyay A; Khilnani K; Shekhawat N
    J AAPOS; 2018 Dec; 22(6):471-473.e1. PubMed ID: 30120984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital lymphangioma. Correlation of magnetic resonance images and intraoperative findings.
    Kazim M; Kennerdell JS; Rothfus W; Marquardt M
    Ophthalmology; 1992 Oct; 99(10):1588-94. PubMed ID: 1454327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Orbital lymphangioma: case report].
    Pereira FJ; Trindade Sde P; Cruz AA; Müller TP
    Arq Bras Oftalmol; 2010; 73(1):84-7. PubMed ID: 20464121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Orbital lymphangioma. A case report].
    Halhal M; El Bakkali M; Benabdellah W; Chefchaouni M; Ouahabi A; Khamlichi A; Berraho A
    J Fr Ophtalmol; 2001 Feb; 24(2):175-9. PubMed ID: 11240491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of orbital lymphangioma with intralesional bleomycin and application of continuous negative pressure.
    Lee KH; Han SH; Yoon JS
    Korean J Ophthalmol; 2015 Feb; 29(1):70-2. PubMed ID: 25646065
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical management, outcomes, and recurrence rate of orbital lymphangiomas.
    Russin JJ; Rangel-Castilla L; Kalani MY; Spetzler RF
    J Clin Neurosci; 2015 May; 22(5):877-82. PubMed ID: 25796957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital venous anomalies.
    Wright JE; Sullivan TJ; Garner A; Wulc AE; Moseley IF
    Ophthalmology; 1997 Jun; 104(6):905-13. PubMed ID: 9186428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital lymphangioma: an analysis of 26 patients.
    Tunç M; Sadri E; Char DH
    Br J Ophthalmol; 1999 Jan; 83(1):76-80. PubMed ID: 10209440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional bleomycin: a potential treatment for refractory orbital lymphangiomas.
    Gooding C; Meyer D
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):e65-7. PubMed ID: 24025999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sotradecol (sodium tetradecyl sulfate) injection of orbital lymphangioma.
    Wojno TH
    Ophthalmic Plast Reconstr Surg; 1999 Nov; 15(6):432-7. PubMed ID: 10588254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing Recurrent Orbital Lymphangioma in a Pubertal Female with Negative Pressure Aspiration and Intralesional Bleomycin Injection: A Case Report.
    Chaudhary S; Pant AR; Badhu BP
    Nepal J Ophthalmol; 2021 Jan; 13(25):157-161. PubMed ID: 33981112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic corticosteroid use in orbital lymphangioma.
    Sires BS; Goins CR; Anderson RL; Holds JB
    Ophthalmic Plast Reconstr Surg; 2001 Mar; 17(2):85-90. PubMed ID: 11281596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of thirty cases of orbital lymphangioma. Pathophysiologic considerations and management recommendations.
    Harris GJ; Sakol PJ; Bonavolontà G; De Conciliis C
    Ophthalmology; 1990 Dec; 97(12):1583-92. PubMed ID: 2087290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A variety of orbital lymphangioma treatments: one case treated with orbital decompression therapy and the other case with intralesional injection of OK-432 therapy].
    Oyama T; Eguchi K; Cho H; Abe H
    Nippon Ganka Gakkai Zasshi; 2009 Jul; 113(7):732-40. PubMed ID: 19637816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misleading presentation of an orbital lymphangioma.
    Nazarian-Mobin SS; Simms K; Urata MM; Tarczy-Hornoch K; Hammoudeh JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):e82-5. PubMed ID: 20031456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtotal excision with adjunctive sclerosing therapy for the treatment of severe symptomatic orbital lymphangiomas.
    Kahana A; Bohnsack BL; Cho RI; Maher CO
    Arch Ophthalmol; 2011 Aug; 129(8):1073-6. PubMed ID: 21825192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.